Lineage Cell Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Lineage Cell Therapeutics, Inc. reported Earnings Per Share Diluted of $0.28 (loss) per share for the year ending 2025.

  • Lineage Cell Therapeutics, Inc. showed a decrease of -211.1% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Lineage Cell Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2015: $0.12 (loss) per share | Q3 2015: $0.18 (loss) per share | Q1 2016: $0.19 (loss) per share | Q2 2016: $0.26 per share | Q3 2016: $0.30 per share | Q1 2017: $0.46 per share | Q2 2017: $0.11 (loss) per share | Q3 2017: $0.12 per share | Q1 2018: $0.50 (loss) per share | Q2 2018: $0.03 (loss) per share | Q3 2018: $0.53 per share | Q1 2019: $0.30 per share | Q2 2019: $0.20 (loss) per share | Q3 2019: $0.11 (loss) per share | Q1 2020: $0.06 (loss) per share | Q2 2020: $0.04 (loss) per share | Q3 2020: $0.05 (loss) per share | Q1 2021: $0.01 (loss) per share | Q2 2021: $0.03 (loss) per share | Q3 2021: $0.05 (loss) per share | Q1 2022: $0.04 (loss) per share | Q2 2022: $0.04 (loss) per share | Q3 2022: $0.04 (loss) per share | Q4 2022: $0.03 (loss) per share | Q1 2023: $0.03 (loss) per share | Q2 2023: $0.03 (loss) per share | Q3 2023: $0.04 (loss) per share | Q4 2023: $0.03 (loss) per share | Q1 2024: $0.04 (loss) per share | Q2 2024: $0.03 (loss) per share | Q3 2024: $0.02 (loss) per share | Q1 2025: $0.02 (loss) per share | Q2 2025: $0.13 (loss) per share | Q3 2025: $0.13 (loss) per share.
  • Over the full 8 years of available data (2014 to 2025), Lineage Cell Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 49.1%.
  • Historical annual values: Fiscal year 2025: $0.28 (loss) per share | Fiscal year 2024: $0.09 (loss) per share | Fiscal year 2023: $0.12 (loss) per share | Fiscal year 2022: $0.15 (loss) per share | Fiscal year 2017: $0.17 (loss) per share | Fiscal year 2016: $0.34 per share | Fiscal year 2015: $0.59 (loss) per share | Fiscal year 2014: $0.55 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: